InflaRx N.V. Common Stock Share Price
NASDAQ: IFRXHealthcare
Live InflaRx N.V. Common Stock Share Price Chart
O H L
InflaRx N.V. Common Stock Performance Overview
Days Range
▼
$2.06Low
$2.10High
Markets Today
| Previous Close | $2.06 |
|---|---|
| Open | $2.06 |
| Volume | 59,813 |
| Day's Range | $2.06 - $2.10 |
| 52W Range | $0.80 - $2.95 |
| Market Cap | $300.63 M |
Historical Performance
| 1M Returns | -5.50 |
|---|---|
| 3M Returns | +13.81 |
| 6M Returns | +134.09 |
| 1Y Returns | +50.36 |
| 5Y Returns | -24.54 |
| 10Y Returns | NA |
InflaRx N.V. Common Stock Fundamentals
| Market Cap | $300.63 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $34.41 K |
| ROE TTM | -0.89 |
| EPS TTM | $-0.57 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.79 |
| EBITDA | $-59.26 M |
| Profit Margin | -155582.08 |
| Market Cap | $300.63 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $34.41 K |
| ROE TTM | -0.89 |
| EPS TTM | $-0.57 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.79 |
| EBITDA | $-59.26 M |
| Profit Margin | -155582.08 |
InflaRx N.V. Common Stock Profit & Loss
Quarterly
| Total Revenue + |
| Gross Profit + |
| Operating Income |
| EBITDA |
| Interest Expense |
| Depreciation |
| Income Before Tax |
| Income Tax Expense |
| Net Income + |
| Net Profit Margin |
InflaRx N.V. Common Stock Financials Balance Sheet In USD
Quarterly
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|
| Share Capital | $4.13 M | $6.03 M | $5.36 M | $7.81 M | $7.41 M | $10.18 M |
| Reserve & Surplus | -$205.02 M | -$243.32 M | -$243.46 M | -$316.30 M | -$345.67 M | -$443.29 M |
| Non-Current Liabilities | $309.16 K | $1.25 M | $1.02 M | $865.12 K | $453.63 K | $795.30 K |
| Current Liabilities | $12.30 M | $21.33 M | $13.03 M | $18.62 M | $14.74 M | $15.23 M |
| Total Liabilities | $12.61 M | $22.58 M | $14.05 M | $19.49 M | $15.19 M | $16.03 M |
| Fixed Assets | $923.69 K | $579.48 K | $467.82 K | $396.19 K | $319.52 K | $389.02 K |
| Current Assets | $105.08 M | $108.80 M | $97.41 M | $121.01 M | $74.56 M | $62.93 M |
| Total Assets | $107.44 M | $142.30 M | $102.40 M | $132.89 M | $79.10 M | $64.78 M |
InflaRx N.V. Common Stock Cash Flow
Quarterly
| Net Income |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
| Change in Cash |
InflaRx N.V. Common Stock Return Calculator
The InflaRx N.V. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,619
Invested Amount$10,000
Est. Returns$-2,381
About InflaRx N.V. Common Stock
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
Popular Stocks
FAQs
What is the share price of InflaRx N.V. Common Stock today?
InflaRx N.V. Common Stock (IFRX) share price as of September 18, 2026 is $2.08. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of InflaRx N.V. Common Stock?
Yes, Indian Investors can invest in the InflaRx N.V. Common Stock (IFRX) Share by opening an international trading account with Angel One.
How can I purchase InflaRx N.V. Common Stock shares in India?
Purchasing InflaRx N.V. Common Stock (IFRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying InflaRx N.V. Common Stock (IFRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of InflaRx N.V. Common Stock?
Yes, you can purchase fractional shares of InflaRx N.V. Common Stock (IFRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of InflaRx N.V. Common Stock?
The market capitalization of InflaRx N.V. Common Stock on September 18, 2026, is $300.63 M.
In which sector InflaRx N.V. Common Stock belongs?
InflaRx N.V. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in InflaRx N.V. Common Stock stocks?
In order to invest in InflaRx N.V. Common Stock (IFRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
